Sridevi Bashyam
Bengaluru, KA, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance.
Journal: Science translational medicine
Published: January 15, 2021
Long-Lasting and Fast-Acting in Vivo Efficacious Antiplasmodial Azepanylcarbazole Amino Alcohol.
Journal: ACS medicinal chemistry letters
Published: September 27, 2017
Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle.
Journal: Journal of medicinal chemistry
Published: October 18, 2016
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines.
Journal: Journal of medicinal chemistry
Published: October 27, 2015
Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains.
Journal: Antimicrobial agents and chemotherapy
Published: December 10, 2014
Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum.
Journal: Malaria journal
Published: April 02, 2014
2,4-Diaminothienopyrimidines as orally active antimalarial agents.
Journal: Journal of medicinal chemistry
Published: January 23, 2014
Structure-activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3,5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in vivo activity.
Journal: Journal of medicinal chemistry
Published: October 09, 2013
Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines.
Journal: Journal of medicinal chemistry
Published: November 30, 2012
3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential.
Journal: Journal of medicinal chemistry
Published: March 07, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026